| Target Price | kr633.93 |
| Price | kr536.00 |
| Potential |
18.27%
register free of charge
|
| Number of Estimates | 4 |
|
4 Analysts have issued a price target MedCap AB 2026 .
The average MedCap AB target price is kr633.93.
This is
18.27%
register free of charge
kr714.00
33.21%
register free of charge
kr568.63
6.09%
register free of charge
|
|
| A rating was issued by 7 analysts: 6 Analysts recommend MedCap AB to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the MedCap AB stock has an average upside potential 2026 of
18.27%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion kr | 1.81 | 2.33 |
| 13.82% | 28.69% | |
| EBITDA Margin | 21.46% | 18.84% |
| 6.38% | 12.20% | |
| Net Margin | 11.48% | 9.52% |
| 5.82% | 17.07% |
4 Analysts have issued a sales forecast MedCap AB 2025 . The average MedCap AB sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an MedCap AB EBITDA forecast 2025. The average MedCap AB EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
3 MedCap AB Analysts have issued a net profit forecast 2025. The average MedCap AB net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share kr | 13.99 | 14.76 |
| 20.71% | 5.50% | |
| P/E | 36.32 | |
| EV/Sales | 3.50 |
3 Analysts have issued a MedCap AB forecast for earnings per share. The average MedCap AB EPS is
This results in the following potential growth metrics and future valuations:
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


